Evidence map›Paper›PMID 32883792›Full record

ArticleMicrobiology resource announcements2020

Complete Genome Sequence of

Hanako Fukano, Hiroshi Miyama, Seiji Takatsuki, Aki Hirabayashi, Masato Suzuki, Mitsunori Yoshida, Yoshifumi Uwamino, Naoki Hasegawa, Yoshihiko Hoshino

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology resource announcements, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Detection ofVirulence · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hanako FukanoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroshi MiyamaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Seiji TakatsukiDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Aki HirabayashiAntimicrobial Resistant Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Masato SuzukiAntimicrobial Resistant Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Mitsunori YoshidaDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshifumi UwaminoDepartment of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
Naoki HasegawaCenter for Infectious Diseases and Infection Control, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0717-7450
Yoshihiko HoshinoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan yhoshino@nih.go.jp.ORCID https://orcid.org/0000-0002-3132-0715

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32883792
PMCPMC7471387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.